A commentary on 'The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs'.
作者信息
He Yawen, Jiang Zhiyang, Zhang Yonghua
机构信息
Hangzhou TCM Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.
出版信息
Int J Surg. 2024 Aug 1;110(8):5250-5251. doi: 10.1097/JS9.0000000000001548.
Abstract
摘要
相似文献
1
A commentary on 'The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs'.
Int J Surg. 2024 Aug 1;110(8):5250-5251. doi: 10.1097/JS9.0000000000001548.
2
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.
JAMA. 2003 Jan 8;289(2):210-6. doi: 10.1001/jama.289.2.210.
3
The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.
Int J Surg. 2024 Jun 1;110(6):3937-3945. doi: 10.1097/JS9.0000000000001381.
4
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients.
Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012.
5
Galantamine for Alzheimer's disease.
Cochrane Database Syst Rev. 2002(3):CD001747. doi: 10.1002/14651858.CD001747.
6
Donepezil for dementia due to Alzheimer's disease.
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
7
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3.
8
Galantamine for Alzheimer's disease.
Cochrane Database Syst Rev. 2001(4):CD001747. doi: 10.1002/14651858.CD001747.
9
Cholinesterase inhibitors for Alzheimer's disease.
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593.
10
Physostigmine for Alzheimer's disease.
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
本文引用的文献
1
The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.
Int J Surg. 2024 Jun 1;110(6):3937-3945. doi: 10.1097/JS9.0000000000001381.
2
A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers.
Alzheimer Dis Assoc Disord. 2023;37(4):290-295. doi: 10.1097/WAD.0000000000000578. Epub 2023 Sep 11.
3
Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil.
J Alzheimers Dis. 2022;90(1):161-172. doi: 10.3233/JAD-220530.
4
Challenges and opportunities in dermal/transdermal delivery.
Ther Deliv. 2010 Jul;1(1):109-31. doi: 10.4155/tde.10.16.
Zotero 插件